- Company/Commercial (6)
- Pharma/Biotech (6)
- Corporate (3)
- Private Equity (3)
- Public Sector/Local Authority (3)
- Real Estate (3)
- Regulatory and compliance (3)
- Employment (2)
- Human Rights (2)
- Agriculture (1)
- Banking / Finance (1)
- Clinical/Medical Negligence (1)
- Commodities (1)
- Construction (1)
- Environment (1)
- Funds (1)
- Information Technology (1)
- Insurance/reinsurance (1)
- Litigation / Dispute Resolution (1)
- Planning (1)
- PPP/PFI/Commercial projects (1)
- Professional Indemnity/Negligence (1)
- Tax (1)
- Travel and Tourism (1)
Sort By: Newest first | Oldest first
David Young, partner and health and safety expert at Eversheds, has commented on the prevalence of campylobacter in supermarket chickens.
A project advised on by Eversheds has been awarded Healthcare Deal of the Year 2014. The deal involved advising the International Finance Corporation on a $37m hospital PPP.
Eversheds has advised NHP on its £477m acquisition by Formation Capital, Safanad and Court Cavendish.
Eversheds has appointed established funds and real-estate tax lawyer Cathryn Vanderspar as the new head of its London tax team.
Eversheds’ Audrey Williams has commented on the findings of research carried out by Bupa that reveal mental-health prejudice in UK organisations.
Eversheds has advised the Cell Therapy Catapult on a partnership with UCL Business (UCLB) and Imperial Innovations.
Eversheds has advised South West Yorkshire Partnership NHS Foundation Trust on a procurement and tendering exercise to find a provider for the future provision of its IT services.
Audrey Williams, partner and head of discrimination at Eversheds, has commented on the European court considering for the first time where obesity sits in legal terms.
Eversheds associate Andrew Bennett has commented on news that Mid Staffordshire NHS Foundation Trust has been fined for health and safety breaches.
Eversheds has advised elderly care provider Four Seasons Healthcare on the acquisition of seven homes from Majesticare.
As test results from a public laboratory in West Yorkshire find more additives in food products, Eversheds’ health and safety partner David Young considers the consequences.
Peter Jones believes that suggestions for reform are a refreshing approach.
Simon Crossley of Eversheds has commented in response to calls from the pharmaceutical industry that the number of medicines being blocked from the UK market by NICE is too high.
Eversheds Ireland has played a key role in the takeover by Endo Health Solutions of Paladin Labs Europe for approximately £1.1bn.
Simon Crossley from Eversheds believes the deal should be a good outcome for industry and government.
Eversheds has commented on proposed new laws governing medical devices being debated in the EU parliament.
Stephen Rose, partner and expert in competition law at Eversheds has commented in response to a joint statement from the Office of Fair Trading, the Competition Commission and Monitor.
Vicky Mann of Eversheds has commented on the news that hidden cameras may form part of a proposed new care home inspection regime in England.
The healthcare team at Eversheds has been named Legal Adviser of the Year at the Laing and Buisson Independent Healthcare Awards 2013.